People

New York attorney, angel investor, and founder of Cytowski & Partners. Advises startups, venture investors, and European founders entering the US market. An early investor in ElevenLabs.

CEO and co-founder of Flourish, developing energy-efficient AI, and a venture partner at Lux Capital. A computational neuroscientist with a Columbia PhD, he co-founded CTRL-labs, acquired by Meta in 2019, and led research on non-invasive neuromotor interfaces using surface EMG. Earlier initiated Microsoft's Internet Explorer project and served as Openwave CTO. Co-author of the 2025 Nature paper on generic neuromotor interfaces for human-computer interaction; joined Columbia's board of trustees in September 2026.

Programmer, essayist and investor who co-founded Y Combinator with Jessica Livingston, Robert Morris and Trevor Blackwell. Previously co-founded Viaweb, acquired by Yahoo in 1998. Writes extensively about startups, entrepreneurship and programming at paulgraham.com; author of Hackers & Painters and books on Lisp, and creator of the Bel programming language. Holds a Harvard PhD in computer science.

Entrepreneur behind Blueprint and the Don't Die community, focused on longevity and health measurement. Founder of Kernel, developing non-invasive brain measurement technology, and OS Fund, which backs science-based companies. His work connects consumer health, neurotechnology and investment in scientific engineering. Appeared at the Network State Conference and on Balaji Srinivasan's Network State podcast. Distinct from Coinbase co-founder Brian Armstrong.

Founder and CEO of Pershing Square, known for concentrated, research-driven investments and active engagement with portfolio companies. Previously co-founded Gotham Partners and worked in real-estate investment banking. Executive chairman of Howard Hughes Holdings and co-trustee of the Pershing Square Foundation, whose philanthropy includes health, medicine and neuroscience. Holds a Harvard MBA and undergraduate degree. In August 2026, announced plans for the Ackman Oxman Institute, focused on brain research, rehabilitation, BCI development and longevity, with venture funding for translating research into patient-facing technologies.

OpenAI co-founder and Head of AI Resilience at the OpenAI Foundation, appointed in March 2026. Works on AI safety, alignment and society's preparedness for advanced AI. Previously led OpenAI teams working on robotics, code generation, language models and human data, with contributions to Codex, GPT-4 and reasoning models. Earned a PhD at NYU with Yann LeCun and Rob Fergus.

Co-founder and Chair of Google DeepMind and Chief Scientist at Alphabet, as listed on Google's current author profile. AI researcher with a background in cognitive neuroscience at UCL, including research on memory and imagination and postdoctoral work at the Gatsby Computational Neuroscience Unit. Co-led the development of AlphaFold and shared the 2024 Nobel Prize in Chemistry. DeepMind's work includes AlphaGo and neuroscience-inspired machine learning.

Professor at UC Davis and director of the Speech Neuroengineering and Cybernetics Lab. Studies speech perception, auditory attention and communication using EEG, fMRI and machine learning, with applications to hearing loss and speech restoration. Holds a joint UCSF/UC Berkeley PhD in bioengineering; joined UC Davis in 2004 after postdoctoral work in cognitive neuroimaging at Berkeley. His research includes brain-based hearing diagnostics and decoding facial-muscle signals to reconstruct speech.

Founder of DeepLearning.AI, Managing General Partner at AI Fund, Managing Partner at AI Aspire, Executive Chairman of LandingAI, and co-founder and chairman of Coursera. An adjunct professor at Stanford, he previously led Google Brain, served as Baidu's chief scientist, and directed the Stanford AI Lab. His work spans machine learning, online education and creating AI companies. Holds a UC Berkeley PhD in computer science.

Professor of AI and robotics at UC Berkeley and an Amazon Scholar. Directs Berkeley's Robot Learning Lab and co-directs the Berkeley Artificial Intelligence Research Lab. Co-founded Covariant and Gradescope and is an investment partner at AIX Ventures. His research spans reinforcement learning, imitation learning, robotic control and foundation models, with contributions including TRPO, MAML and hindsight experience replay. Holds a Stanford PhD in computer science. His main expertise is AI and robotics rather than clinical neurology or EEG.

Founder of Network School, author of The Network State and technology investor. Former CTO of Coinbase and former general partner at Andreessen Horowitz. Co-founded Earn.com, Counsyl, Teleport and Coin Center; his background combines entrepreneurship, crypto infrastructure and genomics research. Holds Stanford degrees including a PhD in electrical engineering. Hosts the Network State podcast, including an interview with Bryan Johnson.

Leads compute at Meta and is an early-stage technology investor, often alongside Nat Friedman through their NFDG partnership. Co-founded Safe Superintelligence and previously co-founded Cue, acquired by Apple in 2013. Ran AI and search projects at Apple from 2013 to 2017 and later served as a Y Combinator partner, starting its AI program. His investments span AI, developer infrastructure and enterprise software.

AI product leader at Meta and technology investor, known for co-founding NFDG with Daniel Gross. Previously CEO of GitHub from 2018 to 2021 and co-founder of Xamarin and Ximian. Supports scientific projects including the Vesuvius Challenge to read ancient Herculaneum scrolls and PlasticList's testing of chemicals in food. Serves on the Arc Institute board.

Technology entrepreneur and investor who runs Gil & Co, a multi-stage investment firm. Co-founded Color Health and Mixer Labs, which was acquired by Twitter, where he became a vice president; previously worked on AI and mobile at Google. An early investor in numerous AI and infrastructure companies, he co-hosts No Priors and wrote High Growth Handbook. Holds an MIT PhD and has supported longevity research and companies.

Chief Executive Officer and co-founder of OpenAI, leading the company developing ChatGPT, frontier AI models and the infrastructure supporting them. Previously president of Y Combinator and co-founder of Loopt. An entrepreneur and technology investor, he writes about startups, economic growth and the long-term implications of AI on his personal blog.

Co-founder of Discovery Loop, launched in 2026 with Sanjay Ghemawat, Quoc Le and Oriol Vinyals to automate machine-learning research and scientific experimentation. Previously Google's Chief Scientist for Google Research and DeepMind and a co-founder of Google Brain, with decades of work on large-scale computing and AI infrastructure. His career includes contributions to MapReduce and Google's machine-learning systems. The current company site and August 2026 founding announcement supersede older Google biographies.

Co-founder of World Labs, developing spatial intelligence and world models, and Sequoia Professor of Computer Science at Stanford. Founding co-director of Stanford's Human-Centered AI Institute; previously directed Stanford's AI Lab and served as Google Cloud's chief scientist for AI/ML during a sabbatical. Known for creating ImageNet and the ImageNet Challenge. Her research spans computer vision, machine learning and cognitive neuroscience.

AI researcher, co-author of the Transformer paper, and co-founder of NEAR Protocol who now leads NEAR AI.

Consumer technology and AI investor who announced his departure from Andreessen Horowitz in 2026 to start his own fund. Previously a16z partner, with investments including ElevenLabs, Function Health, Partiful and Slingshot AI. Earlier worked on growth at Snap and served as CFO at Bungalow. Writes about consumer AI, distribution, engagement and monetization. His own writing identifies @kirbyman01 as his X account.

President and co-founder of OpenAI, working on frontier AI systems, engineering and company strategy. Previously CTO of Stripe, helping grow its engineering organization from an early startup. His projects include OpenAI Gym, OpenAI Five, the OpenAI API and large-scale model training. Writes about software engineering and technology at gregbrockman.com and his personal blog.

Partner at Khosla Ventures

Chief Scientist at OpenAI, appointed in May 2024 after serving as Director of Research. Joined OpenAI in 2017 and led work on GPT-4, OpenAI Five, large-scale reinforcement learning, and deep learning optimization. Holds a PhD in theoretical computer science from Carnegie Mellon University (2016), where his research focused on fast algorithms for high-dimensional convex optimization.

Creator and leader of Base, the Ethereum layer-2 network incubated by Coinbase. Previously led consumer engineering at Coinbase, working on Coinbase, Coinbase Pro, and Coinbase Wallet. Earlier founded Clef and worked as an engineer at BuzzFeed. Also develops open-source software.

Chairman and CEO of Roubini Macro Associates and Professor Emeritus at NYU Stern. His official biography also lists roles as Senior Economic Strategist at Hudson Bay Capital and Chief Economist and Portfolio Manager at Atlas Capital Team. An economist focused on international finance, macroeconomic risk and geopolitics, he previously served at the White House Council of Economic Advisers and the US Treasury. Holds a Harvard PhD and has written extensively on financial crises and global economic risks.

Co-founder and partner at Gigafund; professionally known as Luke Nosek. Co-founded PayPal, where he was VP of Marketing and Strategy, and later co-founded Founders Fund with Peter Thiel and Ken Howery. Led Founders Fund's first SpaceX investment in 2008 and has served on SpaceX's board. Also associated with boards including Last Energy, ResearchGate and Luminous Computing. Focuses on backing ambitious companies over long horizons.

Independent AI researcher and educator producing technical and general-audience courses on neural networks and large language models. A founding member of OpenAI and former Director of AI at Tesla, where he led the Autopilot computer-vision team. Returned to OpenAI in 2023–2024 to build a team working on midtraining and synthetic data. Earned his Stanford PhD with Fei-Fei Li and designed and taught Stanford's CS231n deep-learning course.

Co-founder and Chief Executive Officer of Coinbase, the cryptocurrency platform serving consumers, institutions and developers. Leads the company's work on crypto adoption, economic freedom and financial infrastructure. Writes publicly about Coinbase's strategy, decentralization and building an AI-native company. A speaker in the Network State community. Distinct from Bryan Johnson, the Blueprint and Kernel founder.

Head of MIT's Department of Materials Science and Engineering, Matoula S. Salapatas Professor of Materials Science and Engineering, professor of Brain and Cognitive Sciences, and director of the K. Lisa Yang Brain-Body Center. Leads the Bioelectronics Group, developing multifunctional fibers and magnetic nanomaterials for recording and modulating the brain, spinal cord and peripheral nervous system. Earned her MIT PhD in 2009, completed postdoctoral work at Stanford, and joined MIT's faculty in 2011.

Y. Eva Tan Professor in Neurotechnology at MIT, professor in Brain and Cognitive Sciences, Media Arts and Sciences, and Biological Engineering, and leader of the Synthetic Neurobiology Group. An investigator at the McGovern Institute, he develops tools to analyze and repair neural circuits. Co-invented optogenetic control of neurons and helped develop expansion microscopy and non-invasive brain stimulation methods. Earned his neuroscience PhD at Stanford. Co-founded the Mindspan Institute in 2026 to scale human brain analysis technologies.

Brown University neuroscientist and BrainGate pioneer; became professor emeritus in July 2026 after a 42-year career at Brown and continues working on BrainGate. Previously Henry Merritt Wriston Professor of Neuroscience and professor of engineering. Helped establish intracortical brain-computer interfaces that allow people with paralysis to control computers and assistive devices, and built Brown's brain science research program. His work focuses on restoring communication and voluntary movement through neural interfaces.

CNRS researcher at École Normale Supérieure, currently seconded to Meta AI, where he leads the Brain & AI team. Studies the neural and computational basis of intelligence and language using deep learning with MEG, EEG, electrophysiology and fMRI. His research includes Brain2Qwerty, which decodes typed sentences from non-invasive brain recordings, and models linking speech and language processing in the brain to artificial neural networks.

Postdoctoral scholar in Stanford's Department of Neurosurgery and Neural Prosthetics Translational Laboratory; also publishes as Erin M. Kunz. Completed a Stanford PhD in electrical engineering, advised by Krishna Shenoy and Jaimie Henderson and co-advised by Scott Linderman. Works on machine learning and statistical models for BCI decoding, particularly speech and handwriting. Previously a controls engineer in automated and autonomous driving at General Motors. Co-first author of the 2023 Nature paper A high-performance speech neuroprosthesis.

Assistant Professor of Neurosurgery at Stanford and co-director of the Neural Prosthetics Translational Laboratory. Also publishes as Francis R. Willett. Develops brain-computer interfaces for communication and movement after paralysis, including handwriting decoding and large-vocabulary speech decoding. Earned a PhD in biomedical engineering at Case Western Reserve University, then worked at Stanford as a postdoctoral scholar and research scientist before joining the faculty in 2025. Co-first author of the 2023 Nature paper A high-performance speech neuroprosthesis.

Associate Professor of Neurological Surgery at UC Davis and co-director of the UC Davis Neuroprosthetics Lab with David Brandman. A neuroscientist and neural engineer working across systems neuroscience, computation and AI, he develops implanted brain-computer interfaces to restore communication after paralysis. His work includes speech decoding and expressive voice synthesis for people with ALS, with longer-term interests in language disorders and high-channel-count neural interfaces.

Co-founder and CEO of Hugging Face, the platform and community for sharing and building machine-learning models, datasets and applications. Leads its work on open AI collaboration and commercial partnerships that make models and infrastructure accessible to researchers and developers. Publishes as Clem on Hugging Face, where his interests include multimodal models, time series, biology and chemistry.

Co-founder of Square (now Block), co-founder and General Partner at FINTOP Capital, and founder of FastTrials, which works to streamline clinical trials. Serves on the boards of Block and Emerson Electric. Previously founded LaunchCode, Invisibly and Third Degree Glass Factory. An entrepreneur, inventor and glass artist, he wrote The Innovation Stack about building businesses through interlocking innovations.

Head of Operations and founding team member at Wordware (Sauna by Wordware).

Co-founder of ElevenLabs. Previously worked at Palantir and studied Mathematics at Imperial College London.

Founder of The Thinking Company, angel investor and newsletter author.

A named personal angel participant in Consuma’s October2025 seed financing. His ticket and investment vehicle are undisclosed; no employer or fund participation is inferred.

Named personal angel participant in Consuma’s October2025 seed financing. Equirus’s announcement describes him at that date as Vice President at Titan Capital Winners Fund; his personal investment is not attributed to that fund.

Fynd co-founder and a named personal angel participant in Consuma’s October2025 seed financing.

Founder of Swatantra Wealth and a named personal angel participant in Consuma’s October2025 seed financing.

Founder of Udhyam Learning Foundation and a named personal angel participant in Consuma’s October2025 seed financing.

Tracxn co-founder and a named personal angel participant in Consuma’s October2025 seed financing.

Maya Ghosn Bichara is an angel investor named by Backpack Healthcare as a personal participant in its May2024 Series A. Her own public profile confirms the full-name identity; her personal investment is distinct from Bridge Builders Collaborative.

Divya Silbermann is a philanthropist and founder of Tambourine, identified under that affiliation in Tipping Point Community’s current own board directory. The Giving Pledge lists Ben and Divya Silbermann as joint2021 signatories. Her own public professional post discusses Tambourine’s ALS research support; philanthropic programme commitments are distinct from direct company equity checks. Synapticure’s February2022 seed announcement explicitly names “Ben and Divya Silbermann” together as additional investors. Her personal identity is recorded alongside Ben on the one actual seed financing event with unknown individual allocation, without inferring a Pinterest or Tambourine corporate investment. An authentic self-published portrait was identified, but its public asset host returned403 and no uncertain substitute is used.

Ben Silbermann co-founded Pinterest. Pinterest’s June2022 announcement records his transition from CEO to Executive Chairman, rather than an ongoing CEO appointment. His2025 ASU+GSV speaker biography identifies him as Pinterest Chairman and cofounder, founder of How We Feel and cofounder of Tambourine, with earlier Google work and a Yale degree. The Giving Pledge lists Ben and Divya Silbermann as joint2021 signatories. Synapticure’s February2022 seed announcement explicitly names “Ben and Divya Silbermann” together. Separate personal identities are recorded on that single company financing event with NULL individual allocations; the joint wording does not establish two separate paid tickets or a Pinterest corporate check.

Rohan Seth co-founded Clubhouse and Lydian Accelerator. His self-published Clubhouse profile and founder letter confirm the Clubhouse affiliation. Gold House’s name-bound profile describes his CTO/cofounder work, earlier Memry Labs venture acquired by Opendoor, product work at Opendoor and engineering on Google’s Android, Maps and location services. It lists a Stanford computer-science bachelor’s degree and a management-science-and-engineering master’s degree. His nonprofit’s own account describes Lydian Accelerator’s work to accelerate research for rare genetic diseases; this mission is not a claim of proven treatment. Synapticure personally names Rohan Seth, qualified by Clubhouse, as a seed investor; no Clubhouse corporate check is inferred.

Gerald E. “Gary” Bisbee was a healthcare entrepreneur, author and investor. His2021 AJMC author biography identifies him as cofounder and CEO of Think Medium and host of healthcare-leadership interviews. His longtime collaborator David W. Johnson’s March14,2023 memorial records his death in2023 and career as cofounder of the Health Management Academy and Think Medium, including healthcare banking, academic and policy work. He earned a Wharton MBA and Yale doctorate in chronic-disease epidemiology. Synapticure’s February2022 launch identifies Gerald E. “Gary” Bisbee personally, with the historical Cerner affiliation, as a seed investor. This is the same healthcare leader memorialized under Gary Bisbee, not another similarly named individual; no current Cerner board appointment or corporate check is inferred.

Joe Kraus is a technology entrepreneur and investor whom Lime’s own October2019 publication identifies as its President after moving from a partner position at Google Ventures. Lime again quoted him as President in November2023. These are dated historical affiliations; the current English leadership directory does not establish that he still holds that title. Synapticure names Joe Kraus personally, qualified by Lime, among investors in its seed round closed in earlyfall2021 and announced February2022. No Lime or GV corporate investment follows from that identity wording. Name-bound original publisher portraits were identified but their public asset hosts returned403; no uncertain headshot was substituted.

David Hodgson is Vice Chairman of General Atlantic, whose current biography says he joined in1982 as its third investment professional and has worked across the firm’s investment sectors for more than40years. He holds a Dartmouth AB in mathematics and social sciences and an MBA from Stanford Graduate School of Business. Dartmouth’s2012 trustee announcement independently identifies David C. Hodgson as this same General Atlantic investor. Synapticure’s February2022 launch names David Hodgson personally among its seed investors; this personal participation does not establish a General Atlantic corporate check. An authentic current employer portrait was identified but its public host returned403, so no substitute picture is asserted.

Jeffrey Walker, published as Jeff Walker by Bridge Builders Collaborative, is an investment partner focused on contemplation and mind training. Former CEO and co-founder of CCMP Capital and former JPMorgan Chase vice chairman; his published background also includes social-enterprise investing, New Profit and co-founding Npower.

Vijay A. Balasubramaniyan is Pindrop’s currently published CEO and co-founder, with over two decades of experience in communications security and a Georgia Tech computer-science PhD. Codoxo’s originalJune12,2017 issuer funding announcement explicitly names him among personal investors in its1.5M seed. This personal check is distinct from his company and is not inferred from a board position.

Noam Stern co-founded Financial Algorithms (FINAL), an Israeli algorithmic trading business. Beaconcure identifies him as an investor from its inception, a former early chairman and current published board member. His degrees are in electrical engineering from the Technion and economics from Tel Aviv University. The exact subscriber vehicle, dates and size of his historical Beaconcure investment are unpublished.

Matthew Oristano is Qubigen’s published strategic adviser and investor. The company names him as its representative for partnerships and investor engagement at2025 industry events.

Daniel Gartenberg is a sleep scientist, founder and CEO of SleepSpace, and an entrepreneur with a doctorate in human factors and applied cognition. His TED speaker biography describes sleep-technology and wearable-app research and a Penn State adjunct appointment. His own Wefunder investment profile identifies an investment in Neurosity during its 2023 community campaign. This is a personal investment, with no inferred company board role or attribution of SleepSpace’s research grants to Neurosity. SleepSpace’s current founder and CEO Daniel Gartenberg is a sleep scientist whose doctorate is in human factors and applied cognition. The company describes wearable and nearable measurement, auditory sleep-stimulation research, clinician-facing behavioral support and the Dr. Snooze AI product. NIH and NSF grants belong to the research company, separately from his personal Neurosity investment; his existing biography, portrait and affiliations are preserved.

Jonathan H. F. Crystal founded Crystal Venture Partners and serves as Managing Partner. His background is in strategic risk advisory and insurance: after consulting, he joined his family’s Crystal & Company brokerage, became CFO in2014 and helped combine it with Alliant in2018. His own professional biography and conference material identify a Princeton public-and-international-affairs degree. He built the insurance-focused venture strategy and led its USD33M first-fund final close announcedOctober6,2025. Portfolio-company involvement is an institutional affiliation, not an inferred personal investment check. Comulate’s February 2025 issuer announcement explicitly names Jonathan Crystal personally among its earlier investors and quotes him as Crystal Venture Partners managing partner and former Crystal & Company CFO. The firm separately lists Comulate as a pre-fund investment. This source-qualified personal relationship is not duplicated as a Fund I or manager cash check.

SPREAD lists Christian Schulz as an external senior executive adviser. Former CFO at Traton RENK Group. Source qualification: current own directory reviewedOctober8,2026; no unpublished personal education, appointment day or investor ticket inferred. This is an advisory affiliation, not an assumed employee, statutory director or personal investment. Christian Schulz is independently named an actual personal SeriesB investor only in the financing release.

James Glyn Thomas, publicly James Thomas, serves on Trismik’s board as the Cambridge Enterprise Ventures investor representative. His own financing post says he provided earlier consultancy support and also invested personally; that private investment is distinguished from Cambridge Enterprise’s institutional participation. The official director register confirms his full legal name and July23,2025 appointment. James Thomas is publicly named by Cambridge Angels in its selected individual-member directory. Membership is an angel-network affiliation: individual investment choices are independent, and membership alone does not prove personal investment in any portfolio company.

Jesper Theill Eriksen is Chief Executive Officer of Templafy, an enterprise AI document-generation and automation company. The company’s published September2026 leadership identifies him as CEO, and its March27,2026 data-processing agreement is signed in that capacity. He also represented the business in its April2020, June2021 and July2022 primary financing announcements, discussing global expansion and document-workflow productivity. His corporate role does not establish a personal funding participation.

Preben Damgaard was the founder and former CEO of Damgaard Company. He and his brother Erik founded Damgaard Data in 1983, developing business-management software; the business listed in 1999 and merged with Navision in 2000 before Microsoft acquired Navision in 2002. He subsequently held an executive role in Microsoft Business Solutions in Europe, the Middle East and Africa. Damgaard Company’s own legacy biography dates the investment business to 2003 and describes his support for software entrepreneurs through capital, board work and business advice. He died in 2022. His founder and executive affiliation is explicitly historical; the earlier Microsoft transaction is not a Damgaard investment-fund close, and company portfolio relationships do not establish his personal investment allocation.

Kenneth Iversen is ReMoni's published board chairman and an identified shareholder. His company biography describes more than30 years as CEO of Unimerco, where he developed an international industrial business. The historical Capnova announcement reports his DKK20M investment when Capnova exited; the source does not distinguish secondary purchase from new issuer cash. ReMoni separately announced prospective matching private investment for a2020 ultrasound-metering project. No unspecified private investment vehicle or completed matching payment is inferred. This is the genuine named company portrait.

Peter Sarlin is a co-founder of SiloAI and professor of practice at Aalto University, as identified in QMill’s March7,2025issuer announcement of his personal angel investment. This is a personal check, not a SiloAI, AMD or other manager investment.

Pekka Lundmark is published by QMill as Board Member. Former President and CEO of Nokia with earlier executive experience in communications, energy and industry. Own QMill March2026newsroom and current company posts corroborate continuing board affiliation.

Pierre Meyers is explicitly named by Acticor Biotech as a participating individual subscriber in its completed November28,2023 capital increase. The issuer does not publish his individual ticket or an employer identity in that financing release. No corporate alias, company employment or unrelated homonymous biography is assumed.

A pharmaceutical entrepreneur who founded Mediolanum farmaceutici in Milan in1972 and supported the company’s international and research activities. Acticor Biotech last publicly listed this person as Board Member (historical, pre-liquidation). These affiliations precede the company’s January2025 judicial liquidation; current employment and exact role-end dates are unpublished.

Alain Decombe is a corporate and private-equity attorney at Dechert. The firm’s May 2021 announcement identifies him as Paris office leader and Deputy Chair for International Operations; its December 2025 Stago transaction announcement confirms his continuing partner status. His primary firm profile describes an international legal career and extensive healthcare transaction work. Historical leadership titles are time-qualified rather than asserted current. ESSEC Business Angels’ October 2022 announcement explicitly names him as a private DeepLife investor. His personal investment is distinct from legal advice and is not attributed to Dechert. The authentic portrait is extracted unchanged from his named firm-published profile.

Didier Valet is a published Founder and General Partner of European seed-stage venture firm Varsity. The current native directory provides his named portrait and describes his strategic and financial support of founders. His own earlier announcement describes more than 70 angel investments preceding Varsity. ESSEC Business Angels’ October 2022 DeepLife financing announcement explicitly names him as a private investor. That historical personal investment is not assigned to the later Varsity manager or a fund, and its allocation is undisclosed.

Sylvain Gariel co-founded DNA Script in 2014 with Thomas Ybert and Xavier Godron and co-invented its enzymatic DNA synthesis technology. DNA Script’s October 2020 primary release identifies him as COO and an MIT Innovator Under 35 honoree. His published career includes engineering training at Mines Paris and Corps des Mines. These DNA Script operating titles are historical source-confirmed positions; continuation is not inferred from older announcements. The primary October 2022 DeepLife raise names him as a private investor, with undisclosed allocation. His authentic named portrait is published by Institut Choiseul.

Filippo Monteleone founded Careit in 2016 and is its published founding president. His own biography describes almost 30 years of healthcare investment and corporate experience, including 15 years at Ramsay Générale de Santé, where he was Deputy CEO. He began his career at Worms & Cie in 1994 and became Investment Director. The primary October 2022 DeepLife financing announcement explicitly names him as a private investor. His DeepLife investment is not automatically a Careit corporate check, and his allocation is unpublished.

Stéphane Imbert is the founder of LS Group, originally Light & Shadows, established in 2009 to develop virtual-reality and industrial visualization applications. He founded PiXYZ in 2017 and sold it to Unity in 2021. His own company’s June 2023 profile explicitly describes his subsequent financing and support of UVR, Robeauté and DeepLife. The October 2022 ESSEC Business Angels announcement independently names him as a private participant in DeepLife’s EUR 6M financing. His individual allocation is undisclosed; this personal investment is not assigned to LS Group or Unity.

Bernard Majoie (1939–2021) was a pharmaceutical research executive and entrepreneurial philanthropist. He spent more than35 years developing Laboratoires Fournier’s research activities and founded the Fournier-Majoie Foundation in2006 with part of his personal wealth. He chaired it for more than a decade before passing the presidency to his son Jérôme. reMYND’s2018 financing announcement explicitly names Dr Bernard Majoie as an existing shareholder participating in its round; this personal attribution is retained separately from the foundation and does not imply that the foundation was the subscriber. His photograph and death are documented in the foundation’s own2021 memorial.

René Chaze is a director of NeuroVision Imaging and a Partner at Tiny Orange Capital. His experience spans strategy, operations and finance across technology and life-science investments. He previously served as CFO, COO and head of mergers and acquisitions at Edelman Financial Services and was an Ernst & Young partner. NeuroVision’s current own board biography identifies René Chaze as Partner at Tiny Orange Capital, focusing on high-growth technology including blockchain, digital assets and life sciences. He brings more than 35 years of strategy, operations and finance experience, previously CFO, COO and head of M&A at Edelman Financial Services and an Ernst & Young partner. Board and manager roles do not imply a personal investment. René Chaze is named a Durin director in the issuer’s2019–2025 SEC disclosures. His separate current NeuroVision director and Tiny Orange Capital partner affiliations remain preserved. Board service does not alone prove personal investment; any NJEDA-reported investment requires distinct ticket/date qualification.

Diplom-Ingenieur Friedrich Papst is an Austrian industrial executive and investor, explicitly named as a PIUR IMAGING co-investor by its closed2026 SeriesB crowdfunding campaign. His own ANDRITZ2014 annualreport and2022 corporatehistory establish his mechanicalengineering studies at TechnicalUniversityGraz, joiningANDRITZ1979, and formerexecutiveboard career. ANDRITZ’s own announcement records his retirementMarch31,2015 aftermorethan35years; a currentSchuler corporatepage lists him as a supervisoryboardmember and formerANDRITZexecutive. Austria’s officialregister identifies him as a managingdirector of dpaequity&consultingGmbH FN445755y sinceJanuary19,2016, and PIUR’s currentregister separately lists dpaequity as a corporate shareholder. The campaign’s literalindividualname is retained without asserting that he personally paid a specific currentticket or replacing it with an inferred dpa legalpayer. This is distinct from the unrelated youngerHeineken namesake and unrelated deceasedPapst. His authenticportrait is the company’s named2014 annualreport photograph; its age does not imply currentANDRITZ employment.

Professor Dr Heinz-Walter Grosse (German spelling Große) is a published PIUR IMAGING co-investor and a current individually named shareholder in the Austrian company register, enteredSeptember9,2026; the register date is not a verified cash-closing date. His current own CHBGroup biography identifies him as Chairman of its AdvisoryBoard and establishes the exact formerB.Braun identity: financeemployee1978, CFO2005, vicechair2009, CEO/managementboardchairApril2011–March2019, and Aesculap supervisorychair2018–March2023. He is not described as the currentB.Braun CEO or currentAesculapchair. The closed2026 PIURSeriesB crowdfunding campaign explicitly lists ProfDrHeinz-WalterGrosse as a co-investor, but does not disclose a personal new ticket, instrument or commitment day. This attribution remains a source-qualified campaign roster participation; his ownership or advisory positions are not converted into additional cash transactions.

Dorit Posdorf is a business angel in the encourageventures network. Living Brain’s own July11,2022 seed announcement explicitly identifies her as an individual investor alongside Ina Schlie, separately from the Companisto network. Her personal allocation is undisclosed. encourageventures publishes her named member portrait; no investment by the network association is inferred from her membership.

Ina Schlie is a business angel, supervisory-board member and former SAP executive. She initiated and co-founded the encourageventures female-investor network. Living Brain’s own July11,2022 seed announcement explicitly names her personal investment and quotes her support for the company; her individual allocation is undisclosed. The network’s own named member portrait establishes her identity.

Intelecy founder who moved from CEO to focus on product development as CTO when Camilla Gjetvik was appointed in January 2024. Current CTO tenure is not separately reaffirmed by the executive directory.

Industrial software executive with more than 25 years in software, including Microsoft and leadership of Cognite’s partner and alliances business.

Nkechi Iregbulem is an investor and technology professional with experience in early-stage investing and a published Clear Ventures deep-tech fellowship biography. She appeared as a HICO Ventures investor in a November2025 event listing and remains named in HICO’s website people menu, but the linked profile is unavailable. Her current HICO role and tenure are unconfirmed; no HICO institutional portfolio check is inferred as her personal investment. Her own May2024 public announcement explicitly reports an angel investment in Neros, and her March2025 retrospective states that she invested since its pre-seed. This personally sourced investment is distinct from any HICO employer participation; exact ticket and payment day remain unpublished.

David (Dave) Baszucki is the founder and CEO of Roblox. Roblox’s own leadership biography identifies his earlier founding of Knowledge Revolution and its Interactive Physics software, subsequent sale to MSC Software, and Stanford University electrical-engineering education. Akili’s May26,2021 financing announcement explicitly names Dave Baszucki, founder and CEO of Roblox, as an individual investor in its USD110M SeriesD. This is a personal investment attribution; it does not establish a Roblox corporate investment, an Akili board appointment, or an individual ticket amount.

John Santelli is the Chief Executive Officer of Solera Health, as confirmed by its current official leadership page. Penguin Ai expressly names the former UnitedHealthcare chief information officer as an individual angel investor in its2024 seed financing. This personal investment is distinct from any UnitedHealth Group, Optum or institutional-fund holding, and he is distinct from the Columbia physician with the same name.

Previously healthcare CIO at Capital BlueCross and Optum; issuer September 2025 states he first invested personally, then advised and joined as CSO. Current tenure not reconfirmed.

Varsha Rao is a healthcare and technology operator, angel investor and published Flare Capital executive partner. Her current manager biography describes previous leadership at Nurx, Clover Health and Airbnb, as well as founding Eve.com. She studied at the University of Pennsylvania and Harvard Business School. SignalFire’s own January2025 investment announcement names her as an actual Qualified Health angel participant. Nurx is treated as a previous employer, despite older personal-site biographies retaining its CEO title. Her authentic portrait comes from Flare Capital’s own named profile.

Bill Veghte is a technology executive and Athene Partners founder published among Qualified Health’s investors and advisers. His background covers software products, operations and enterprise growth across companies including Microsoft and Hewlett Packard. SignalFire’s own January2025 investment article explicitly names him as a participating angel, separate from his advisory affiliation. His individual ticket size remains undisclosed.

Eric Larsen is a healthcare strategist and adviser published in Qualified Health’s investor and adviser roster. His career includes leadership at the Advisory Board Company and work on health-system partnerships following its Optum acquisition. The company’s materials also identify venture-investing and board experience. Differing historical institutional titles are retained as published context rather than asserted as current employer appointments.

Has been an Alto director since September 2021. Co-founded Lighthouse Capital Partners and was its founding managing director until 2017. Her current Alto biography also identifies a Sofina board role and nonprofit trusteeships. She holds Harvard undergraduate and MBA degrees.

Founded Alto in 2019 after a career as a tenured Stanford professor of psychiatry and behavioral sciences. His clinical neuroscience laboratory also worked at the Palo Alto Veterans Affairs Medical Center. Alto’s current biography identifies him as founder, chief executive and board chair.

Biotechnology entrepreneur and individual investor. She cofounded 23andMe in 2006; 23andMe Research Institute's current own governance directory identifies her as founder and CEO of the nonprofit institute. Treehub's 2026 launch interview identifies an operating-partner affiliation. Clair Health's transaction counsel separately names Anne as a personal investor in its June 2026 seed financing; that individual check is distinct from Treehub's fund participation and from corporate investment by 23andMe.

Scott Sandell is executive chairman and chief investment officer of New Enterprise Associates (NEA). Its current biography says he previously served as CEO and managing general partner, joined in 1996, and led investments in technology businesses including Bloom Energy, Cloudflare, Robinhood, Salesforce, Tableau and Workday. He is a founding director of Venture Forward and an adjunct lecturer at Stanford. Bridge Neurotech’s October 2026 founder letter separately names Scott Sandell personally among its investors; that personal attribution does not establish an investment by NEA.

Karna D. Shinde is a personal angel investor and lawyer whose own KDS Global website describes a focus on medtech, deep technology and AR/VR. He publishes neuro42 and Promaxo among his investments. His investment amounts and round attribution are not disclosed on his own portfolio page; broad portfolio performance and regulatory claims are not independently adopted.

Physician and surgical-robotics entrepreneur who co-founded Intuitive Surgical and Auris Health. neuro42's October 2023 issuer announcement identifies him as a founding partner of Sonder Capital and confirms a direct personal investment and strategic-advisor appointment. The investment is attributed personally; no investment by Sonder, Intuitive or Johnson & Johnson is inferred.

Personal angel investor named in neuro42's July 2021 closed Series A announcement. The issuer does not disclose his individual ticket or provide a biography sufficient to identify unrelated same-name professionals.

Entrepreneur and personal deep-technology investor. neuro42's July 2021 Series A issuer announcement names Krishna R. Bhupal as an angel participant. Its October 2023 announcement appoints him to the board and describes investment interests in energy, hospitality, retail, real estate and medtech; continued board status is not independently established by the current team directory.

David Spreng founded Runway Growth Capital in 2015 and is President, a director and, from August 2026, Co-CEO of the externally managed BDC Runway Growth Finance. His investing background includes venture capital and growth lending. He also co-founded Decathlon Capital Partners. The adviser Co-CIO role is separate from his BDC executive positions.

Erik Thoresen joined BOKA in 2022 as a partner and served on Infleqtion’s board from 2022 through its 2026 NYSE listing. He previously worked at Calaveras Capital, BNY Mellon Wealth Management, E*TRADE Financial and the U.S. Trade and Development Agency. He is a CFA charterholder and holds an MBA from the University of Virginia’s Darden School. His former Infleqtion board role does not establish current directorship.

S. Tyler Hollmig is a dermatology professor and director of dermatologic surgery and laser/cosmetic dermatology at UT Austin Dell Medical School. He trained at UT Southwestern, Stanford and the Medical University of South Carolina. Venus Concept named him as an independent director and personal common-stock financing participant in November 2022; historical board status is not assumed to remain current after the 2026 take-private.

Hemanth Varghese is a healthcare executive who served as President and Chief Operating Officer of Venus Concept before departing on March 28, 2025. His earlier company roles included Chief Business Officer and oversight of medical device innovation. The issuer explicitly named him as a personal common-stock participant in its November 18, 2022 financing; this investment is separate from employer investments.

Rajiv De Silva became a transition special advisor to Venus Concept in September 2026 after serving as its CEO. He was one of the personal common-stock participants named in its November 2022 financing.

Pukar C. Hamal founded and leads SecurityPal, developing cybersecurity assurance software with AI and human expert oversight. Nuon personally named him as an angel investor in its December2024 combined funding announcement; this is distinct from a SecurityPal corporate investment.

John Kodumal co-founded LaunchDarkly and serves as its CTO. Nuon’s current investor directory identifies him as an individual investor; it does not publish his investment date, amount or round allocation.

Chris Riccomini is an investor associated with Materialized View and a personally named Nuon investor. Nuon lists his participation individually rather than as a corporate Materialized View investment.

Richie Artoul co-founded WarpStream and is a personally named Nuon investor. The company’s current investor directory and December2024 announcement identify him individually, without publishing a ticket or specific financing allocation.

Michael Grinich is the founder and CEO of WorkOS and a personally named investor in Nuon. His investment does not imply a corporate WorkOS subscription or a Nuon employee role.

Quinn Slack is a Sourcegraph co-founder and CEO, personally named as a Nuon investor in its combined seed and Series A funding announcement. His personal investment is distinct from a Sourcegraph corporate investment.

Matt Kozlov is published by Techstars as MD Emeritus (alumni directory). This is an alumni/advisory directory affiliation and does not establish a current full-time managing-director appointment. The current published directory verifies the named affiliation; exact appointment dates are undisclosed.

Robert Meese, also known as Bob Meese, is Chief Business Officer of Duolingo, which states he joined in September2016 after working at Google. He holds computer science and economics degrees from the University of Pennsylvania and an MIT MBA. Fundamental Research Labs names Bob Meese as a personal investor in its May2024 seed round, distinct from an investment by Duolingo.

Greg Harper is a games industry executive and personal technology investor. Fundamental Research Labs’ May2024 issuer announcement identifies him as a Supercell executive board member and names him as a personal seed investor. His self-published profile and corresponding portrait confirm the identity. The Supercell position is qualified to the transaction announcement rather than asserted as a new current appointment.

Stephen Lim is a founder and Product Director of Raid Base. Its current official biography describes eight years at Riot Games in project-lead and vice president of research and development roles, including co-creation of Valorant. He is named as a personal investor in Fundamental Research Labs’ May2024 seed round, distinct from any investment by Riot Games or Raid Base.

Mitch Lasky is a former game industry executive and former Benchmark Capital general partner associated with early investments in Riot Games, Snapchat and Discord. His self-published profile identifies him as co-host of the GameCraft podcast and co-owner and board member of LAFC. He is named as a personal investor in Fundamental Research Labs’ May2024 seed round; this is separate from an institutional Benchmark investment.

Zachary Weiner, also known as Zack Weiner, co-founded the sports media and entertainment company Overtime and was publicly identified by the company as president. Fundamental Research Labs identifies the Overtime co-founder as a personal participant in its January2024 pre-seed round. This is distinct from the Chase designer and lawyers with similar names; no current executive appointment date is inferred.

Joon Sung Park is a computer scientist studying generative AI agents and simulations of human societies. He earned a Stanford computer science PhD in 2025 and is co-founder and CEO of Simile, as identified in his June2026 curriculum vitae. His work includes the 2023 Generative Agents study. Fundamental Research Labs identifies him as a personal participant in its January2024 pre-seed round.

Clene board chairman sinceMay2021 and director sinceDecember2020. Co-founded MatlinPatterson and formerly served as its CEO; has medical device, biotechnology and public company board experience.

Clene founding CEO and President, previously a founding commercial leader at Actelion with pharmaceutical sales and marketing experience. His legal name in SEC filings is Robert Etherington.

Amar Shah is a machine learning researcher, entrepreneur and deep-tech angel investor, known as a co-founder and former CEO of Wayve. Fractile named him as a personal angel investor in its July2024 seed. His current interview profile identifies his work with Dhyan Ventures and CHARM Therapeutics; these affiliations are distinct from his personal investment.

Stan Boland is a UK technology entrepreneur and semiconductor investor. He co-founded FiveAI, previously co-founded and led Element14 and Icera, and served as CEO of Acorn. Fractile named him as a personal angel investor in its July2024 seed. Stan Boland is publicly named by Cambridge Angels in its selected individual-member directory. Membership is an angel-network affiliation: individual investment choices are independent, and membership alone does not prove personal investment in any portfolio company.

Co-founder, CEO and board chairman of Fin, the AI customer-agent company founded as Intercom in2011 and renamed in2026. He earlier founded software design company Contrast and developer toolkit Exceptional. He is a personally named investor in Paradigm AI’s USD2 million pre-seed financing; no Fin or Intercom corporate check is implied.

Co-founder and CEO of LangChain, developing infrastructure for AI agents and applications. He is a personally named investor in Paradigm AI’s USD2 million pre-seed financing, according to its August2025 launch release; this is distinct from a LangChain corporate investment.

Mark Stevenson is former COO of Thermo Fisher Scientific and a named personal investor in Relation Therapeutics’ June2022 seed financing.

Peer Schatz is former CEO of Qiagen and a named personal investor in Relation Therapeutics’ June2022 seed financing.

Jonathan Milner founded Abcam and is an angel investor in Relation Therapeutics. Relation explicitly names him in its June2022 seed and March2024 additional seed financings. Jonathan Milner is listed by Cambridge Innovation Capital as advisory panel member. Founded Abcam and trained in molecular genetics; his published background includes support for early life-science ventures. This affiliation follows CIC’s published directory; other career appointments are scoped to its biography and do not imply personal investment tickets. Jonathan Milner co-founded Abcam and the Milner Therapeutics Institute. Start Codon identifies him as a founding backer, while Companies House records his historical Ltd director appointment15April2019–3December2021. Its current owner identifies Meltwind as his diligence/portfolio-management team; no undisclosed personal ticket or current Start Codon director appointment is inferred. Jonathan Milner is publicly named by Cambridge Angels in its selected individual-member directory. Membership is an angel-network affiliation: individual investment choices are independent, and membership alone does not prove personal investment in any portfolio company.

Philipp Schulte-Noelle is a healthcare executive and angel investor in nyra health. The company and its financing counsel confirm his participation in the 2023 seed; its 2026 Series A announcement names him as a returning investor, corroborated by Austria's official shareholder register.

Stefan Speiser is a healthcare entrepreneur associated with Latido and an angel investor. Nyra health's December 2021 issuer announcement confirms his participation in its pre-seed financing.

Franz Wiesbauer is a healthcare entrepreneur associated with Medmastery and an angel investor. Nyra health's December 2021 issuer announcement names him as a pre-seed participant.

Sievert Weiss is a healthcare entrepreneur associated with AMBOSS and an angel investor. Nyra health's December 2021 issuer announcement confirms his participation in its pre-seed financing.

Lukas Zinnagl is a healthcare entrepreneur and angel investor associated with Diagnosia. Nyra health's December 2021 issuer announcement names him as a participating business angel in its pre-seed financing.

Johannes Braith is an entrepreneur and early-stage investor. Nyra health's December 2021 announcement identifies the Storebox founder as lead investor in its EUR2.2 million pre-seed financing and as a Hardlymountain Capital co-founder.

Clinical and basic immunologist and biotechnology entrepreneur who founded Tolerance Bio and co-founded Provention Bio, Celimmune and Glutenostics. He is also a personal investor in ONESTX. His career includes immunology research and drug development at NIH, BMS, MedImmune and Janssen.

Co-founder and executive chairman of Ovid Therapeutics. Served as CEO before transitioning to executive chairman on January 1, 2026. Previously led Teva and strategic alliances at Novartis, and held executive leadership at Bristol Myers Squibb. Also chairs Gensaic’s board according to Ovid’s June 2026 quarterly filing. Distinct from Bessemer investor Jeremy Levine. He is also chairman of Gensaic’s board, as confirmed by Gensaic’s current directory and Ovid’s June 2026 filing.

President and chief executive of ProMIS Neurosciences and a member of its board. Biotechnology executive with experience leading drug development companies and advancing therapeutics toward commercialization.

Tom Peterson is chief executive officer of Blackbird Health, which he joined as CEO in 2023 after his family’s experience with its clinical model. SignalFire’s current biography identifies him as co-founder and former chief operating officer of Evolent Health, and describes prior leadership of the Advisory Board Company’s technology and consulting divisions. He studied at Harvard and earned a master’s degree in mental-health counseling at George Washington University. His existing SignalFire advisor identity and external role are preserved.

Frank Williams co-founded Evolent Health and previously led the Advisory Board Company. Qualified Health publishes him among its investors and advisers, and SignalFire’s January2025 investment announcement explicitly names him as a participating angel. His background covers healthcare services, technology and public-company growth. Existing SignalFire-related identity and roles are preserved; Evolent board status is not treated as a Qualified Health board appointment. Frank Williams is publicly listed as an advisor to GreyMatter Capital. The manager’s own directory describes the professional background as: Co-Founder, Evolent Health. This directory caption describes outside affiliations and experience; it does not establish current employment at those organizations or a GreyMatter executive position.

Technology entrepreneur and individual biotechnology investor. Nimbus Therapeutics' financing announcements explicitly name Bill Gates as an investor; those personal investments are distinct from Gates Frontier, Gates Ventures and the Gates Foundation. Gates Foundation public biography: As chair of the Gates Foundation, Bill Gates shapes and approves foundation strategies, advocates for the foundation’s issues, and sets the organization’s overall direction. He works with grantees and partners to further the foundation’s goal of improving equity in the United States and around the world. Bill co-founded Microsoft Corporation in 1975 with Paul Allen and led the company to become the worldwide leader in business and personal software and services. In 2008, Bill transitioned to focus full-time on the foundation’s work. Through his private office, Gates Ventures, he pursues his work in climate change and clean energy innovation, Alzheimer’s research and other healthcare issues, interdisciplinary education, and technology. He is also the founder of Breakthrough Energy, which works to address climate change by supporting the next generation of entrepreneurs, big thinkers, and clean technologies. If we are going to change people’s lives, we need another level of innovation. Not just technology innovation – system innovation. - Bill Gates Chair and Board Member Bill Gates established Gates Ventures as his private executive office in September 2008. The office supports his work through research, innovation, partnerships and investment activities. This institutional affiliation is separate from his personal investor identity and the Gates Foundation.

Troy Wilson is listed by Montara Therapeutics as Chair of the Board.

Former chief information officer at General Atlantic and Carlyle, named as an angel investor in Tracelight’s August 2025 seed financing.

Former Partner of Sequoia Capital, according to Rapta's June 2025 issuer financing announcement. Named personal investor in Rapta's seed round.

Founder of DW Fritz Automation, which Rapta's June 2025 financing announcement identifies as acquired by Sandvik in 2021. Named personal investor in Rapta's seed round.

Fred Robertson: Director, EnsoData.

Justin Mortara: CEO, President and Director, EnsoData.

Mike Masters is publicly listed by BioCircuit Technologies as Director. This affiliation reflects the company's published board directory; continuation of an independent board after the October 2026 Axogen acquisition is not established by that listing. Michael W. Masters is managing member and controlling founder of Masters Special Situations and founder of Masters Capital Management. The firms and his personal investments are distinct. His existing BioCircuit board biography and portrait are preserved.

Angel investor named in Turn-Motion’s September 2026 pre-seed financing announcement.

Angel investor named in Turn-Motion’s September 2026 pre-seed financing announcement.

Angel investor named in Turn-Motion’s September 2026 pre-seed financing announcement.

Entrepreneur and former Klevu founder, named as an angel investor in Farang’s August2025 seed round.

Entrepreneur and former Klevu founder, named as an angel investor in Farang’s August2025 seed round.

MapLight Therapeutics co-founder, chief executive and director; also serves on Stellaromics’ board. Physician and biotechnology executive who previously led Cardioxyl and OvaScience and invested at The Aurora Funds.

Rich Aldrich serves as Co-Founder and Partner at Longwood Fund, a biotechnology company builder and life sciences venture investor.

Casey Tansey is a USVP general partner who joined inApril2005 after operating medical-device companies. His investment interests include minimally invasive devices, cardiovascular care, orthopedics and neurology. He led Epicor Medical through its acquisition by St.Jude Medical and previously led Heartport and worked at Baxter’s cardiovascular division. Published portfolio board relationships include Luminopia, MicroTransponder, Neuros Medical, ShiraTronics and HeartFlow. He holds BS and MBA degrees from the College of Notre Dame in Belmont. Casey Tansey is listed by Mobia Medical (formerly MicroTransponder) as Board Member. He is a managing partner at U.S. Venture Partners; the Mobia SEC prospectus separately discloses a personal USD2 million 2026 convertible-note investment, distinct from USVP institutional funds. Casey Tansey is a current Iantrek board member; the company identifies his U.S. Venture Partners general-partner affiliation. Institutional fund participation is distinct from personal investing.

Business angel named as an investor in Maculaser's 2021 financing.

Co-founded Cosmos Ventures after working as an investor at Union Square Ventures. Studied philosophy and computer science at Harvard and developed the firm’s investment thesis with Brendan McCord.

Co-founded Cosmos Ventures and founded the nonprofit Cosmos Institute. Previously founded AI businesses and helped establish the Pentagon’s applied AI organization and strategy.

Business angel named by Kyto-Prod founder Olfa Kilani as a participant in the company's first financing in 2019.

Microsoft AI vice president and a publicly named individual investor in Deplike.

Yemeksepeti co-founder and a publicly named individual investor in Deplike.

Gram Games co-founder and a publicly named individual investor in Deplike.

Udemy co-founder and a publicly named individual investor in Deplike.

Jonathan Userovici appears in Idinvest Partners’ August2020 primary directory as Investment Manager. The role belonged to the historical European investment manager’s published investment, investor-relations or corporate support platform, spanning venture/growth, private debt and dedicated portfolios. The named historical role is distinguished from the preserved later Eurazeo affiliations. Idinvest became Eurazeo Investment Manager and was subsequently absorbed into Eurazeo Global Investor. Joining and departure days and unpublished prior career or education details are not inferred.

Franco Danesi is a Black Opal venture partner. Its published career summary identifies venture investing and investment management, investment-banking experience at Goldman Sachs and Morgan Stanley and London Business School education. The embedded metadata misspells his surname as Daneis; the displayed biography and current team identify Danesi, matching the preserved existing person.

David Cummings is publicly named by Cambridge Angels in its selected individual-member directory. Membership is an angel-network affiliation: individual investment choices are independent, and membership alone does not prove personal investment in any portfolio company.

Healthcare technology entrepreneur and angel investor. Datamonk's October 2025 announcement identifies him as founder of Applicare, Forcare and HealthSage AI and a participant in its pre-seed financing.

Healthcare technology executive and angel investor. Datamonk's October 2025 financing announcement identifies him as former Chief Innovation and Strategy Officer at Philips and a participant in its pre-seed financing.

Technologist and investor focused on semiconductors, quantum technology and computing infrastructure, with earlier McKinsey and MIT Lincoln Laboratory experience.

Brings operational experience at UP.Partners and DoorDash, including capital formation and robotics commercialization, with computer science, neuroscience and robotics training.

Engineering leader with earlier experience developing robotic fulfillment systems at Fulfil and energy and robotics programs at Tesla.

Technology operator and investor with experience in semiconductors, systems, enterprise software and cybersecurity.

Robotics researcher, Kuna founder and investor focused on robotics, logistics, manufacturing, transportation and AI.

HardTech investor and company builder with electrical engineering and biology training at Caltech.

Adam Boehler is an investor and strategic adviser to Cortica. The company’s 2021 financing announcement identifies him as an individual participating investor, Rubicon Founders CEO, Landmark Health founder and former director of the Center for Medicare and Medicaid Innovation.